Real-time enrollment status for this central nervous system lymphoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 1:46 PM UTC
| NCT Number | NCT05625594 |
| Recruiting Status | Recruiting |
| Condition | Central Nervous System Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | June 3, 2026 (Jun 3, 2026) |
As of August 31, 2026: Clinical trial NCT05625594 is currently recruiting participants. This phase1 study for central nervous system lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05625594 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05625594 was last updated Jun 3, 2026 (June 3, 2026). HelloStudys verifies this status automatically.